VEON VEON
Company Profile ↓Company Overview
VEON (VEON) is a publicly traded company listed on with a market capitalization of $100.82B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 39.7%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 18.6%.
Trades at an undemanding P/E of 7.3.
Operating margin of 24.4% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $4.40B (+9.9% YoY); net profit $532.00M.
- Trailing 12 Months Year-on-year growth — revenue +9.9%, earnings +28.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.42% |
| 1 Year: | 9.87% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 28.19% |
Stock Price Performance
| 1 Year: | +7.85% |
| 6 Months: | +2.73% |
| 3 Months: | +10.95% |
| 1 Month: | +4.64% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)60.14 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 39.7%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.09B | 1.11B | 1.17B | 1.20B | 1.27B |
| Cost of Revenue | - | 104.00M | 133.00M | 160.00M | 151.00M | 171.00M |
| Gross Profit | - | 983.00M | 982.00M | 1.01B | 1.05B | 1.10B |
| Operating Expenses | - | 659.00M | 825.00M | 662.00M | 742.00M | 773.00M |
| Operating Income | - | 324.00M | 157.00M | 349.00M | 308.00M | 327.00M |
| EBITDA | - | 1.00B | 254.00M | 437.00M | 542.00M | 592.00M |
| Interest Expense | - | 127.00M | 132.00M | 177.00M | 150.00M | 167.00M |
| Pretax Income | - | 682.00M | -83.00M | 56.00M | 183.00M | 200.00M |
| Tax Provision | - | 74.00M | 44.00M | 64.00M | 60.00M | 60.00M |
| Net Income | - | 595.00M | -131.00M | -31.00M | 99.00M | 122.00M |
| Diluted EPS | 1.50 | 8.50 | -1.91 | - | 1.50 | 1.75 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 3.75B | 3.70B | 4.00B | 4.40B |
| Cost of Revenue | - | 476.00M | 441.00M | 515.00M | 526.00M |
| Gross Profit | - | 3.28B | 3.26B | 3.49B | 3.87B |
| Operating Expenses | - | 2.28B | 2.37B | 2.51B | 2.80B |
| Operating Income | - | 997.00M | 891.00M | 983.00M | 1.07B |
| EBITDA | - | 2.16B | 1.82B | 1.93B | 2.13B |
| Interest Expense | - | 583.00M | 531.00M | 495.00M | 535.00M |
| Pretax Income | - | 802.00M | 559.00M | 704.00M | 785.00M |
| Tax Provision | - | 69.00M | 179.00M | 217.00M | 194.00M |
| Net Income | - | -162.00M | -2.53B | 415.00M | 532.00M |
| Diluted EPS | - | -4.52 | -35.93 | 5.73 | 7.50 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 15.08B | 8.22B | 8.04B | 9.21B |
| Current Assets | 9.77B | 3.16B | 2.88B | 3.11B |
| Cash & Equivalents | 3.11B | 1.90B | 1.69B | 1.73B |
| Inventory | 18.00M | 23.00M | 15.00M | 32.00M |
| Receivables | 446.00M | 412.00M | 177.00M | 249.00M |
| Total Liabilities | 14.32B | 7.15B | 6.78B | 7.58B |
| Current Liabilities | 8.88B | 3.58B | 3.65B | 3.44B |
| Long Term Debt | - | - | - | - |
| Total Debt | 8.18B | 5.16B | 4.69B | 5.14B |
| Total Equity | 569.00M | 858.00M | 1.10B | 1.34B |
| Shares Outstanding | 1.76B | 1.76B | 1.77B | 1.85B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 2.56B | 2.11B | 1.15B | 1.35B |
| Investing Cash Flow | - | -1.66B | -2.24B | -778.00M | -791.00M |
| Financing Cash Flow | - | 116.00M | -1.15B | -551.00M | -548.00M |
| Capital Expenditure | - | -1.01B | -766.00M | -907.00M | -949.00M |
| Free Cash Flow | - | 1.55B | 1.34B | 243.00M | 404.00M |
| Net Change in Cash | - | 963.00M | -1.17B | -193.00M | 28.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 87.3% | 88.1% | 87.1% | 88.0% |
| Operating Margin % | - | 26.6% | 24.1% | 24.6% | 24.4% |
| Net Margin % | - | -4.3% | -68.4% | 10.4% | 12.1% |
| ROE % | - | -28.5% | -294.6% | 37.8% | 39.7% |
| ROCE % | - | 16.1% | 19.2% | 22.4% | 18.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VEON
VEON (NasdaqGS:VEON) Stock Ignores Profit Rebuild As Digital Momentum Strengthens - simplywall.st
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPME42bVgyek5vSWtaMVJzS0dKTVpENjJWNk9nUlZjLVBZXzJ1NUhKRXdFTW1xOE9wVEdBUlFKT2RzT1hoSTZFNkt2aDBQU2dYWjFGWlh3VzR2U2UtZVNBQjBnY2QxSUxEQnJGQjZxbmhPeFVOZzRpTU5SMllQVl9tLUcxUE5mbnp1WV9zWE…
VEON Ltd(VEON) Stock Options Chain | Quotes & News - Moomoo
<a href="https://news.google.com/rss/articles/CBMilANBVV95cUxNZnRHa3lqbGoxN2VDTXQ0VFZwdVJxQ2FPWXNvdmZYTl9tTnRMUWgwcmtYelZ4Tk5vRjBlWEprelRETW9VcF9PUk14a0xTUnlYclMzZ2owbVRfa2hVdW40TFdyY1BiWjhhZ1JvQV9LWEF5QVgxdjVDbXFZOThjbVJ4SlJuQmNKdFhrSUxVLU…
VEON LTD ($VEON) Releases Q2 2026 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOT2RsSnhNY1hlcE1YWjlsUjMycjBOcFpxNzlQYTFJODJMLUhjX3F0WHhJOWN1YVQ4Sm9ULU1TVnZ5T0pLT0VsQnZDVVdjcEdoc1Uza0ZxM3hZR3J3VkIzWXNTbHdiTzN3ZGlYVEswbjROUjNwOHFXTjBTaUVKUXNEdEtXWGV6SHA2?oc=5"…
VEON digital services reach 227.7 million customers in 2Q26 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNSDdfdmN0VGItSWdsQTJqeE1Dd2pJTkZYNnNoVFMzUXlIbWxiUkF3TjJSakhFWGdDc0M4Nm9oSUMzSVBJNFVNREExcFZGX2NWUTRKNEw3OGlnQ0w5TmNTX1UzUklDeXRiWFh6ZTZaQmw4ZXJkdzhIVlBwczBXOHFhaG43alRSRG9wQkp1dX…
VEON Q2 Earnings Call Highlights - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQU2hHamRhcXp0M3JiZ20tOXJjekszY0FKT3B6c3RlUkNtVWwyWTQwUFJNYnpzWm9kdi1BYjBqdV9HWWRPbnZmYU0xejlldFRPaVBZWEpfdkF2dGFxbTFXaXlNSjBLd0lFVzJCRG1mQ2ZMZ2t0UExJYndZWmlROE9vSDhoYkZWZEJvWllHMX…
Understanding the Setup: (VEON) and Scalable Risk - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPVDlTYkdUOGhsb0RqNFZ4SWczdm5id3dHZGhaZzBYeHlCcEVFd3ZqVkFsTUZiN28xaWlUaEs4Yy02NnlpYl85TXJWUm1PQmR0bFRpTzlLeXlCR0dNNGVoZUxxakhManpaMXpfSjdnbENORm1EWWFmakluTFU2bm5NRS13OURLMUJyS3FwRD…
VEON — Frequently Asked Questions
What is the current share price of VEON?
As of 2026-08-05 17:25 PDT, VEON trades at $54.52 on NASDAQ/NYSE. Its 52-week range is $43.57 to $62.72.
What is the market capitalisation of VEON?
VEON has a market capitalisation of $100.82B on NASDAQ/NYSE.
What is the P/E ratio of VEON?
VEON trades at a trailing price-to-earnings (P/E) ratio of 7.27. Its price-to-book (P/B) ratio is 75.24.
What is the return on equity (ROE) of VEON?
VEON has a return on equity (ROE) of 39.70%. Its return on capital employed (ROCE) is 18.55%.
Is VEON a good stock to buy?
This page provides a data-driven analysis of VEON, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.